Healthcare diagnostics startup Neuranics raised $700K Seed funding from IPV

Inflection Point Ventures (IPV) is leading the $700K seed round for the healthcare diagnostics startup Neuranics.

The money raised will go toward clinical validation and technology development, which will help the business move closer to commercial production after CDSCO licensing.

Neuranics, which was founded in 2021 by Praveen Kumar and Ashutosh Patra, is working on a point-of-care blood analyzer that can use a finger prick sample to provide complete blood count (CBC) results in less than ten minutes. With its high efficiency and low maintenance requirements, this primary and emergency-use device is revolutionizing the healthcare sector.

At the same time, life-saving therapies can be started right away for serious illnesses like sepsis, severe anemia, and thrombocytopenia, particularly in dengue patients, guaranteeing prompt and efficient care.

The business is moving forward with clinical trials, has a granted patent, the CDSCO Test License, and AIIMS Delhi’s Ethical Approval.

Inflection Point Ventures has invested more than Rs 790 crore in more than 210 startups to date.